Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

21 hematology centers in Turkey will participate in this noninterventional observational study. The recruitment target is 960 cases. Patients will be followed-up at least 1 year or to the end of the study according to the physicians' discretion, or withdrawal of consent. Recruitment period will be 36 months. Data will be collected via electronic case report form. Since the study cohort does not include only newly diagnosed patients, all aTTP patients will be included to the study, previous treatments and diagnosis information data could also be collected from hospital records. Patients recruitment duration: 3 years (36 months) Patients follow-up duration: 1 year (12 months)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Diagnosed as aTTP after 01.01.2015

• Patients with ADAMS13\<10%

• Thrombocytopenia (\<100.000)

• Coombs (-)

• Microangiopathic hemolytic amenia

• 18 years and older

Locations
Other Locations
Turkey
Baskent Universtiy Faculty of Medicine
RECRUITING
Ankara
Contact Information
Primary
ilker kurkcu
ilker.kurkcu@sentez-cro.com
+905326354515
Time Frame
Start Date: 2022-12-21
Estimated Completion Date: 2026-12-21
Participants
Target number of participants: 960
Treatments
All Patients
Non interventional observational
Related Therapeutic Areas
Sponsors
Leads: Turkish Hematology Association
Collaborators: Sanofi

This content was sourced from clinicaltrials.gov